People with diabetes should pay double attention to their feet in taking care of them. Diabetic complications such as diabetic foot can be prevented with sufficient care. Diabetes is a complex disease, and people need to be aware of its symptoms and consequences.

Currently, there are more than 14 million people with diabetes in Brazil as per the International Diabetes Federation, South and Central America. Diabetic patients should be regularly evaluated for health and presence of complications. If appropriate treatment is provided in the early stages of the pathology, severe situations like amputation can be prevented.

There is limited awareness among people suffering with diabetes that regular foot care can prevent fungal infections such as mycosis. The infections appear superficial but can cause deep wounds. Care should be taken to keep feet clean, moisturized, protected by proper footwear prescribed by a medical specialist and never walk barefoot.

According to the agency, the class III controversial contraceptive device can cause menstrual bleeding, chronic pain, and unwanted pregnancy. The device can also trigger allergies, perforation and migration of device.

ANVISA could not confirm the sales volume in Brazil however, Bayer estimates the approximately 900,000 devices have been sold across the globe, with at least 70% in the US.

The device was introduced as a quick half hour procedure with reduced discomfort and faster recovery then traditional tubal ligation. Essure coils are inserted and “screwed” into the fallopian tubes in an outpatient procedure. The coils triggers inflammation and scar-tissue growth to block fertilization.

Bayer protects its products and says “appropriate option for a majority of women seeking a permanent form of birth control.” However, the US FDA in 2016 had issued a black box warning as it received reports on side effects (9,900), including 26 deaths and many pregnancy losses, between November 2002 and December 2015. Essure System in Brazil was registered by the company Comercial Commed Produtos Hospitalares Ltda. The Brazilian agency has ordered the suspension of the import, distribution and marketing, use and disclosure of the product throughout the country.